de la Monte, Suzanne

Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease

de la Monte, S. M., Sohn, Y. K., & Wands, J. R. (1997) · Journal of the Neurological Sciences

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 307

Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma

Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew, M. C., Trepo, C., & Wands, J. R. (2004) · Gastroenterology

Wnt/β-catenin signaling in development and cancerHepatocellular Carcinoma Treatment and Prognosis

Cited by 249

Cloning of human GAP 43: Growth association and ischemic resurgence

Ng, S.-C., de la Monte, S. M., Conboy, G. L., Karns, L. R., & Fishman, M. C. (1988) · Neuron

Nerve injury and regenerationAxon Guidance and Neuronal Signaling

Cited by 150

Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines

Ott, B. R., Jones, R. N., Daiello, L. A., de la Monte, S. M., Stopa, E. G., Johanson, C. E., Denby, C., & Grammas, P. (2018) · Frontiers in Aging Neuroscience

Barrier Structure and Function StudiesCerebrospinal fluid and hydrocephalus

Cited by 91

mTORC2 (Rictor) in Alzheimer’s Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons

Lee, H.-K., Kwon, B., Lemere, C. A., de la Monte, S., Itamura, K., Ha, A. Y., & Querfurth, H. W. (2017) · Journal of Alzheimer's Disease

Alzheimer's disease research and treatmentsPI3K/AKT/mTOR signaling in cancer

Cited by 57